Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of Neurovirology|July 9, 2019
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patientsMassimiliano Fabbiani, Nicoletta Ciccarelli, Valeria Castelli, et al.
Sexually Transmitted Diseases|May 9, 2025
Knowledge, Use, and Misuse of Self-Prescribed Doxycycline Postexposure Prophylaxis in a Community-Based Preexposure Prophylaxis ServiceRoberto Rossotti, Enrico Caruso, Daniele Calzavara, et al.
Journal of Medical Virology|May 31, 2022
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practiceAlberto Borghetti, Damiano Farinacci, Arturo Ciccullo, et al.
Infectious Diseases and Therapy|July 8, 2026
Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV on Any Antiretroviral Therapy Regimen: The Retrospective ESSENTIAL StudyMaria Vittoria Cossu, Davide Moschese, Maddalena Matone, et al.
Open Forum Infectious Diseases|July 10, 2026
Extreme Cardiovascular Risk and LDL-C Target Achievement in People With HIVAndrea Giacomelli, Anna Lisa Ridolfo, Letizia Oreni, et al.
HIV Medicine|February 23, 2026
Achieving reimbursable PrEP is insufficient to increase and diversify the users attending community-based servicesEnrico Caruso, Alessandro Tavelli, Anna De Bona, et al.
Pathogens (Basel, Switzerland)|July 28, 2026
Repeated Detection of Vaccine-Preventable Anal HPV Genotypes in a Screened Cohort: A Retrospective Observational StudyAlberto Rizzo, Davide Moschese, Federica Salari, et al.
BMC Infectious Diseases|January 19, 2019
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practiceAlberto Borghetti, Francesca Lombardi, Roberta Gagliardini, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 16, 2018
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ARTFrancesca Lombardi, Simone Belmonti, Lucrezia Rapone, et al.
IJID Regions|April 3, 2025
Effectiveness and safety of tenofovir alafenamide/emtricitabine/bictegravir as a first-line regimen in people with HIV: A retrospective observational studyAndrea Giacomelli, Maria Vittoria Cossu, Davide Moschese, et al.
Pageof 6